Cargando…
P624: PHASE 1 STUDY OF JNJ-67856633, A FIRST-IN-HUMAN HIGHLY SELECTIVE MALT1 INHIBITOR, IN RELAPSED/REFRACTORY (R/R) B-CELL NON-HODGKIN LYMPHOMA (B-NHL) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429444/ http://dx.doi.org/10.1097/01.HS9.0000969400.60782.b9 |
| _version_ | 1785090714742292480 |
|---|---|
| author | Kalac, Matko Hertzberg, Mark Cheah, Chan Ribrag, Vincent Abrisquet Acosta, Pablo Opat, Stephen Bachy, Emmanuel Ysebaert, Loïc Qiu, Lihua Yi, Shuhua Nishimura, Noriko Lemech, Charlotte Bussolari, Jacqueline Deng, Changchun Lu, Tianbao Xiu, Liang Van Hemelryck, Sandy Philippar, Ulrike Guo, Yue Soete, Virginie Soriano, Isabel Fourneau, Nele Gerecitano, John Morschhauser, Franck |
| author_facet | Kalac, Matko Hertzberg, Mark Cheah, Chan Ribrag, Vincent Abrisquet Acosta, Pablo Opat, Stephen Bachy, Emmanuel Ysebaert, Loïc Qiu, Lihua Yi, Shuhua Nishimura, Noriko Lemech, Charlotte Bussolari, Jacqueline Deng, Changchun Lu, Tianbao Xiu, Liang Van Hemelryck, Sandy Philippar, Ulrike Guo, Yue Soete, Virginie Soriano, Isabel Fourneau, Nele Gerecitano, John Morschhauser, Franck |
| author_sort | Kalac, Matko |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429444 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104294442023-08-17 P624: PHASE 1 STUDY OF JNJ-67856633, A FIRST-IN-HUMAN HIGHLY SELECTIVE MALT1 INHIBITOR, IN RELAPSED/REFRACTORY (R/R) B-CELL NON-HODGKIN LYMPHOMA (B-NHL) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) Kalac, Matko Hertzberg, Mark Cheah, Chan Ribrag, Vincent Abrisquet Acosta, Pablo Opat, Stephen Bachy, Emmanuel Ysebaert, Loïc Qiu, Lihua Yi, Shuhua Nishimura, Noriko Lemech, Charlotte Bussolari, Jacqueline Deng, Changchun Lu, Tianbao Xiu, Liang Van Hemelryck, Sandy Philippar, Ulrike Guo, Yue Soete, Virginie Soriano, Isabel Fourneau, Nele Gerecitano, John Morschhauser, Franck Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429444/ http://dx.doi.org/10.1097/01.HS9.0000969400.60782.b9 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Kalac, Matko Hertzberg, Mark Cheah, Chan Ribrag, Vincent Abrisquet Acosta, Pablo Opat, Stephen Bachy, Emmanuel Ysebaert, Loïc Qiu, Lihua Yi, Shuhua Nishimura, Noriko Lemech, Charlotte Bussolari, Jacqueline Deng, Changchun Lu, Tianbao Xiu, Liang Van Hemelryck, Sandy Philippar, Ulrike Guo, Yue Soete, Virginie Soriano, Isabel Fourneau, Nele Gerecitano, John Morschhauser, Franck P624: PHASE 1 STUDY OF JNJ-67856633, A FIRST-IN-HUMAN HIGHLY SELECTIVE MALT1 INHIBITOR, IN RELAPSED/REFRACTORY (R/R) B-CELL NON-HODGKIN LYMPHOMA (B-NHL) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) |
| title | P624: PHASE 1 STUDY OF JNJ-67856633, A FIRST-IN-HUMAN HIGHLY SELECTIVE MALT1 INHIBITOR, IN RELAPSED/REFRACTORY (R/R) B-CELL NON-HODGKIN LYMPHOMA (B-NHL) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) |
| title_full | P624: PHASE 1 STUDY OF JNJ-67856633, A FIRST-IN-HUMAN HIGHLY SELECTIVE MALT1 INHIBITOR, IN RELAPSED/REFRACTORY (R/R) B-CELL NON-HODGKIN LYMPHOMA (B-NHL) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) |
| title_fullStr | P624: PHASE 1 STUDY OF JNJ-67856633, A FIRST-IN-HUMAN HIGHLY SELECTIVE MALT1 INHIBITOR, IN RELAPSED/REFRACTORY (R/R) B-CELL NON-HODGKIN LYMPHOMA (B-NHL) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) |
| title_full_unstemmed | P624: PHASE 1 STUDY OF JNJ-67856633, A FIRST-IN-HUMAN HIGHLY SELECTIVE MALT1 INHIBITOR, IN RELAPSED/REFRACTORY (R/R) B-CELL NON-HODGKIN LYMPHOMA (B-NHL) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) |
| title_short | P624: PHASE 1 STUDY OF JNJ-67856633, A FIRST-IN-HUMAN HIGHLY SELECTIVE MALT1 INHIBITOR, IN RELAPSED/REFRACTORY (R/R) B-CELL NON-HODGKIN LYMPHOMA (B-NHL) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) |
| title_sort | p624: phase 1 study of jnj-67856633, a first-in-human highly selective malt1 inhibitor, in relapsed/refractory (r/r) b-cell non-hodgkin lymphoma (b-nhl) and chronic lymphocytic leukemia (cll) |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429444/ http://dx.doi.org/10.1097/01.HS9.0000969400.60782.b9 |
| work_keys_str_mv | AT kalacmatko p624phase1studyofjnj67856633afirstinhumanhighlyselectivemalt1inhibitorinrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlandchroniclymphocyticleukemiacll AT hertzbergmark p624phase1studyofjnj67856633afirstinhumanhighlyselectivemalt1inhibitorinrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlandchroniclymphocyticleukemiacll AT cheahchan p624phase1studyofjnj67856633afirstinhumanhighlyselectivemalt1inhibitorinrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlandchroniclymphocyticleukemiacll AT ribragvincent p624phase1studyofjnj67856633afirstinhumanhighlyselectivemalt1inhibitorinrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlandchroniclymphocyticleukemiacll AT abrisquetacostapablo p624phase1studyofjnj67856633afirstinhumanhighlyselectivemalt1inhibitorinrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlandchroniclymphocyticleukemiacll AT opatstephen p624phase1studyofjnj67856633afirstinhumanhighlyselectivemalt1inhibitorinrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlandchroniclymphocyticleukemiacll AT bachyemmanuel p624phase1studyofjnj67856633afirstinhumanhighlyselectivemalt1inhibitorinrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlandchroniclymphocyticleukemiacll AT ysebaertloic p624phase1studyofjnj67856633afirstinhumanhighlyselectivemalt1inhibitorinrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlandchroniclymphocyticleukemiacll AT qiulihua p624phase1studyofjnj67856633afirstinhumanhighlyselectivemalt1inhibitorinrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlandchroniclymphocyticleukemiacll AT yishuhua p624phase1studyofjnj67856633afirstinhumanhighlyselectivemalt1inhibitorinrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlandchroniclymphocyticleukemiacll AT nishimuranoriko p624phase1studyofjnj67856633afirstinhumanhighlyselectivemalt1inhibitorinrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlandchroniclymphocyticleukemiacll AT lemechcharlotte p624phase1studyofjnj67856633afirstinhumanhighlyselectivemalt1inhibitorinrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlandchroniclymphocyticleukemiacll AT bussolarijacqueline p624phase1studyofjnj67856633afirstinhumanhighlyselectivemalt1inhibitorinrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlandchroniclymphocyticleukemiacll AT dengchangchun p624phase1studyofjnj67856633afirstinhumanhighlyselectivemalt1inhibitorinrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlandchroniclymphocyticleukemiacll AT lutianbao p624phase1studyofjnj67856633afirstinhumanhighlyselectivemalt1inhibitorinrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlandchroniclymphocyticleukemiacll AT xiuliang p624phase1studyofjnj67856633afirstinhumanhighlyselectivemalt1inhibitorinrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlandchroniclymphocyticleukemiacll AT vanhemelrycksandy p624phase1studyofjnj67856633afirstinhumanhighlyselectivemalt1inhibitorinrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlandchroniclymphocyticleukemiacll AT philipparulrike p624phase1studyofjnj67856633afirstinhumanhighlyselectivemalt1inhibitorinrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlandchroniclymphocyticleukemiacll AT guoyue p624phase1studyofjnj67856633afirstinhumanhighlyselectivemalt1inhibitorinrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlandchroniclymphocyticleukemiacll AT soetevirginie p624phase1studyofjnj67856633afirstinhumanhighlyselectivemalt1inhibitorinrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlandchroniclymphocyticleukemiacll AT sorianoisabel p624phase1studyofjnj67856633afirstinhumanhighlyselectivemalt1inhibitorinrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlandchroniclymphocyticleukemiacll AT fourneaunele p624phase1studyofjnj67856633afirstinhumanhighlyselectivemalt1inhibitorinrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlandchroniclymphocyticleukemiacll AT gerecitanojohn p624phase1studyofjnj67856633afirstinhumanhighlyselectivemalt1inhibitorinrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlandchroniclymphocyticleukemiacll AT morschhauserfranck p624phase1studyofjnj67856633afirstinhumanhighlyselectivemalt1inhibitorinrelapsedrefractoryrrbcellnonhodgkinlymphomabnhlandchroniclymphocyticleukemiacll |